https://www.bioworld.com/articles/726301-mabloc-and-instituto-butantan-partner-on-mbl-yfv-01?v=preview
Mabloc LLC has established a strategic partnership with Instituto Butantan to co-develop and manufacture MBL-YFV-01, a monoclonal antibody therapy for yellow...
instituto butantanpartnermblyfv